Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

EC approves combination treatment for kidney cancer

March 31, 2021 Research and Development Cancer, Europe, oncology

The European Commission (EC) has approved Ipsen’s Cabometyx in combination with Opdivo as a first-line treatment for advanced renal cell …
News

Celonic to manufacture at least 100 million CureVac COVID-19 jabs

March 31, 2021 Research and Development COVID-19, COVID-19 vaccine, CureVac, colonic, vaccine production

Celonic are to manufacture more than 100 million doses of CureVac’s COVID-19 vaccine, with 50 million shots expected to be …
News

Arecor receives £2.8m grant for rapid insulin product

March 31, 2021 Research and Development diabetes, insulin

Arecor has announced today that it has received a £2.8 million grant from Innovate UK, to support the Phase II …
News
COVID-19 virus

Pharmafile.com’s weekly COVID-19 news round-up

March 24, 2021 Research and Development COVID-19, covid 19 news, covid-19 news, news roundup

The past week has seen plenty of positive COVID-19 news; the Oxford-AstraZeneca vaccine was deemed safe and effective by the …
News

Roche’s drug cocktail reduces hospitalisation due to COVID-19 in Phase III trial

March 24, 2021 Research and Development COVID-19, Roche, covid-19 treatment

Roche’s antibody drug combination of casirivimab and imdevimab has shown to reduce hospitalisation or death by 70% in non-hospitalised patients …
News

Pfizer and Myovant’s menstrual blood loss treatment reports 78% effectiveness

March 24, 2021 Research and Development Myovant, Pfizer, Phase III trial, fibroids, uterine fibroids

Pfizer and Myovant Science’s relugolix treatment to reduce menstrual blood loss in women with uterine fibroids has shown promising results …
News

Novo Nordisk obesity treatment successful in clinical trials

March 24, 2021 Research and Development Novo Nordisk, obesity

New results from Novo Nordisk’s Phase III study on obesity saw clinically relevant weight loss, without weight regain, in people …
News

Guerbet see positive Phase III results for MRI agent

March 24, 2021 Research and Development MRI

Medical imaging company, Guerbet, have announced the success of its Phase III study into the safety and efficacy of Gadopiclenol, …
News
covid-19 virus

Pharmafile.com’s weekly COVID-19 news round-up

March 17, 2021 Research and Development COVID-19, covid-19 roundup, news roundup

The past week has seen a mix of good and bad COVID-19 news; the Oxford-AstraZeneca vaccine rollout has halted throughout …
News
Eli Lilly building

Lilly’s ulcerative colitis treatment meets all key endpoints in Phase III trial

March 17, 2021 Research and Development Eli Lilly, Phase III trial, lilly, mirikizumab, ulcerative colitis

Eli Lilly’s mirikizumab treatment for ulcerative colitis (UC) patients has met the primary endpoints and all key secondary endpoints in …
News

Axol Bioscience and CENSO Biotechnologies enter merger agreement

March 17, 2021 Research and Development Axol Bioscience, Censo Biotechnologies, immune cell, merger, neuroscience

Axol Bioscience, an established provider of iPSC-derived cells, media, and characterisation services, and CENSO Biotechnologies, a cell biology CRO focused …
News

PEP-Therapy and Institut Curie’s cancer drug trial approved in France

March 17, 2021 Research and Development Cancer, France, Pep-therapy

PEP-Therapy and Institut Curie have been granted approval from the French National Agency for Medicines and Health Products (ANSM) to …
News

Medicago & GSK start plant-derived COVID-19 vaccine trial

March 17, 2021 Research and Development COVID-19, GSK

Medicago and GSK have announced the start of Phase III clinical testing of Medicago’s plant-derived COVID-19 vaccine. The vaccine candidate …
News
coronavirus

Pharmafile.com’s weekly COVID-19 news round-up

March 10, 2021 Research and Development COVID, COVID Vaccine, COVID-19, coronavirus, covid round-up

The past week has continued to see positive COVID-19 news; CytoDyn’s treatment for patients with severe symptoms of the virus …
News
lilly_entrance_web

Lilly’s cancer drug Retsevmo gets UK approval for multiple indications

March 10, 2021 Research and Development Cancer, Eli Lilly, MHRA

The MHRA has granted conditional marketing authorisation for Eli Lilly’s Retsevmo (selpercatinib) as monotherapy for a number of cancer indications.
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025